Akdeniz University Hospital

The trials here

What the 10 trials at this site are about, from their registry records.

Conditions

• Lung cancer4 trials
• Colorectal cancer1 trial
• Delirium1 trial
• Diabetic eye disease1 trial
• Glaucoma1 trial
• High blood pressure1 trial
• Macular degeneration1 trial
• Osteoarthritis1 trial
• Prostate cancer1 trial
• Stroke1 trial

Phase

• Phase 33 trials
• Phase 2/31 trial

Status

• Active, not recruiting3 trials
• Recruiting3 trials
• Completed2 trials
• Not yet recruiting1 trial
• Suspended1 trial

Lead sponsor

• Akdeniz University4 trials
• BioNTech SE2 trials
• Daiichi Sankyo2 trials
• ALİ DEMİRTAŞ1 trial
• Ural Telekomunikasyon Sanayi Ticaret Anonim Sirketi1 trial

Running trials

• Not yet recruiting

  Preoperative Breathing Exercise Training and Postoperative Delirium After Robotic Radical Prostatectomy

  NCT07766603· ALİ DEMİRTAŞ· Source

  Contact: ALİ DEMİRTAŞ

• Active, not recruiting

  Generative AI-Supported Personalized Education Compared With Printed Material for Adults With Hypertension

  NCT07776834· Akdeniz University· Source

• Recruiting

  Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

  NCT06712355· Phase 3· BioNTech SE· Source

• Recruiting

  Telerehabilitation-Based Coaching Interventions (TeleSCoP) for Patients With Ischemic Stroke

  NCT05940350· Akdeniz University· Source

  Contact: Hicran Bektas, PhD, RN

• Recruiting

  Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

  NCT06712316· Phase 2/3· BioNTech SE· Source

• Active, not recruiting

  Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

  NCT05555732· Phase 3· Daiichi Sankyo· Source

• Active, not recruiting

  Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations

  NCT05215340· Phase 3· Daiichi Sankyo· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer2 recruiting
• Delirium1 recruiting
• Prostate cancer1 recruiting
• Stroke1 recruiting

Closed trials

• Completed

  Colorectal Cancer Survivor Symptom Management

  NCT05876338· Akdeniz University· Source

• Completed

  Detecting Eye Diseases Via Hybrid Deep Learning Algorithms From Fundus Images

  NCT06213896· Ural Telekomunikasyon Sanayi Ticaret Anonim Sirketi· Source